These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1709504)

  • 1. Absence of luminal bile increases duodenal content of cholecystokinin in rats.
    Miyasaka K; Funakoshi A; Matsumoto M; Jimi A; Shikado F; Kitani K
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):175-80. PubMed ID: 1709504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice.
    Miyasaka K; Funakoshi A; Matsumoto M; Kitani K
    Dig Dis Sci; 1993 Apr; 38(4):674-9. PubMed ID: 8462366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats.
    Nakamura R; Miyasaka K; Funakoshi A; Kitani K
    Proc Soc Exp Biol Med; 1989 Nov; 192(2):182-6. PubMed ID: 2813449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.
    Miyasaka K; Funakoshi A; Jimi A; Nakamura R; Matsumoto M; Kitani K
    Dig Dis Sci; 1992 Mar; 37(3):369-77. PubMed ID: 1735360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion.
    Lu L; Louie D; Owyang C
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G430-5. PubMed ID: 2465698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide.
    Miyasaka K; Guan DF; Liddle RA; Green GM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G175-81. PubMed ID: 2764106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt.
    Ohlsson B; Yusa T; Rehfeld JF; Lundquist I; Ihse I; Axelson J
    Pancreas; 2000 Mar; 20(2):170-6. PubMed ID: 10707933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.
    Fölsch UR; Cantor P; Wilms HM; Schafmayer A; Becker HD; Creutzfeldt W
    Gastroenterology; 1987 Feb; 92(2):449-58. PubMed ID: 2431952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of recovery from pancreatic hypertrophy during partial exclusion of bile-pancreatic juice in rats.
    Miyasaka K; Tateishi K; Matsumoto M; Funakoshi A
    Jpn J Physiol; 1994; 44(3):243-54. PubMed ID: 7823415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of exocrine pancreatic secretion by soybean trypsin inhibitor does not depend on the masking of luminal trypsin activity in rats that have bile-pancreatic juice diverted into the ileum.
    Hira T; Hara H; Kasai T
    Pancreas; 1997 Oct; 15(3):285-90. PubMed ID: 9336793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory capacity of pancreatic protein during luminal feedback regulation in conscious rats.
    Okubo K; Masuda M; Miyasaka K; Funakoshi A
    Jpn J Physiol; 1994; 44(2):205-19. PubMed ID: 7967222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of plasma cholecystokinin levels by bile and bile acids in the rat.
    Ohta H; Guan D; Tawil T; Liddle RA; Green GM
    Gastroenterology; 1990 Sep; 99(3):819-25. PubMed ID: 2379784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.
    Rivard N; Guan D; Maouyo D; Grondin G; Bérubé FL; Morisset J
    Endocrinology; 1991 Dec; 129(6):2867-74. PubMed ID: 1954873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of a synthetic trypsin inhibitor increases pancreatic duct function in CCK-A receptor-deficient rats.
    Kawanami T; Funakoshi A; Suzuki S; Kanai S; Sato Y; Miyasaka K
    Pancreas; 2000 May; 20(4):394-400. PubMed ID: 10824695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of bile flow obstruction vs bile diversion on pancreatic secretion in the conscious rat.
    Kurosawa H; Miyasaka K; Kitani K
    Int J Pancreatol; 1989 Mar; 4(2):187-97. PubMed ID: 2723468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.